REFORM OF EUROPEAN PHARMACEUTICAL LEGISLATION

On April 10, 2024, the proposal for the reform of EU pharmaceutical legislation was approved, for a new European directive and regulation, to promote innovation, guarantee access to medicines and more affordable prices, while supporting research, namely new antibiotics, the competitiveness and attractiveness of the EU pharmaceutical industry, with stricter environmental standards and the strengthening of preparedness and response mechanisms for crisis situations.